NR1H4 and sclerosing cholangitis: Furthermore, treatment with cilofexor—a non-steroidal FXR agonist—improved the histological features of sclerosing cholangitis, cholestasis, and hepatic fibrosis in the Mdr2−/− mouse model of sclerosing cholangitis [72].